CVS Health Corporation (LON:0HRS)
78.69
-0.30 (-0.37%)
At close: Nov 7, 2025
CVS Health Revenue
CVS Health had revenue of $102.24B USD in the quarter ending September 30, 2025, with 7.76% growth. This brings the company's revenue in the last twelve months to $391.69B, up 6.66% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$391.69B
Revenue Growth
+6.66%
P/S Ratio
0.26
Revenue / Employee
$1.31M
Employees
300,000
Market Cap
76.16B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
| Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
| Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
| Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
| Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
CVS Health News
- 1 day ago - Can CVS Health Maintain Its Growth Through the End of 2025? - The Motley Fool
- 2 days ago - Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies - Business Wire
- 4 days ago - Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Nasdaq
- 5 days ago - CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continual "Buy" Rating | CVS ... - GuruFocus
- 5 days ago - Validea Detailed Fundamental Analysis - CVS - Nasdaq
- 6 days ago - CVS Health: Undervalued And Ripe For Growth - Seeking Alpha
- 8 days ago - CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity - PRNewsWire
- 8 days ago - What the Options Market Tells Us About CVS Health - Benzinga